Thu, Nov 19th 2026, 4:00 PM

Thu, Nov 19th 2026, 4:00 PM
Activating mutations in the ligand-binding domain of ESR1 are a major mechanism of acquired resistance to endocrine therapy in ER-positive, HER2-negative advanced breast cancer, emerging in up to 40% of patients.
Their detection is becoming increasingly relevant in clinical research and molecular oncology workflows. Oral selective estrogen receptor degraders (SERDs) have received European marketing authorization for ESR1-mutated disease, including elacestrant after progression on endocrine therapy plus a CDK4/6 inhibitor and camizestrant as an early switch strategy upon emergence of an ESR1 mutation during first-line therapy, before clinical progression.
Although these treatments are not yet reimbursed in Belgium, this shift increases the need for sensitive, rapid, and repeatable ESR1 mutation testing approaches so that laboratories can prepare for potential future access.
Liquid biopsy, based on circulating tumor DNA (ctDNA) from a blood draw, can support minimally invasive and serial monitoring of ESR1 mutations in research and molecular oncology workflows. Multiplex Droplet DigitalTM PCR (ddPCRTM ) is well suited for detecting low-frequency variants across several hotspots in a single reaction, depending on assay design, sample quality, and validation parameters.
Key Learning Objectives:
Speaker’s description
Laras
Pitayu, PharmD, PhD
Interim Product
Manager, Senior Field Application Scientist
Stilla Technologies, a Bio-Rad Laboratories Company
Matthieu
Terwagne, PhD
Expert Scientifique
– Responsable de service adjoint BM Onco-hématologie
Institut de Pathologie et de Génétique ASBL
The content presented in these sessions is intended for research use only and is not intended for use in diagnostic procedures. The views and opinions expressed in the recordings are those of the individual presenters and do not necessarily reflect the official policy, position, or claims of Bio-Rad Laboratories.
Any clinical applications, test validations, or performance claims discussed are the sole responsibility of the presenting institution or speaker and do not reflect the views or endorsements of Bio-Rad Laboratories.
Any reference to clinical use, patient testing, or performance claims reflects the practices and experience of the individual institutions or researchers and should not be interpreted as endorsement by Bio-Rad.
For Research Use Only. Not for use in diagnostic procedures.

Create an account now for exclusive benefits, personalized recommendations, and seamless order tracking. Elevate your lab experience today!